Flower City Capital

Position in OTLK — Outlook Therapeutics, Inc.

CIK 1808394 PITTSFORD, NY

Position in OTLK

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$31,800

+$27,680 QoQ

Shares Held

20,000

0.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#33

of 68 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Flower City Capital holds $929,624 across 5 Biotechnology names. OTLK ranks #5 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	500	$311,770
2	IMRX	Immuneering Corp	55,029	$274,594
3	KURA	Kura Oncology, Inc.	18,000	$197,460
4	PGEN	Precigen, Inc.	20,000	$114,000
5	OTLK	Outlook Therapeutics, Inc. This page	20,000	$31,800

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,800	20,000	0.0%	Shares	Sole	2026-07-07
2026-03-31	$4,120	20,000	0.0%	Shares	Sole	2026-04-14
2025-12-31	$31,600	20,000	0.0%	Shares	Sole	2026-01-22
2025-09-30	$21,200	20,000	-33.3%	Shares	Sole	2025-10-08
2023-12-31	$11,820	30,000	0.0%	Shares	Sole	2024-01-19
2023-09-30	$6,630	30,000	-40.0%	Shares	Sole	2023-10-10
2023-06-30	$87,000	50,000	-7.4%	Shares	Sole	2023-07-24
2023-03-31	$58,870	54,010	0.0%	Shares	Sole	2023-04-18
2022-12-31	$58,330	54,010	+4.3%	Shares	Sole	2023-01-11
2022-09-30	$63,169	51,778	0.0%	Shares	Sole	2022-10-07
2022-06-30	$52,813	51,778	+158.9%	Shares	Sole	2022-07-12
2022-03-31	$35,600	20,000	—	Shares	Sole	2022-04-14
No filing history on record for this holder in this stock.